www.senology.org

 Newsletter

"Join  the senologic and oncologic  scientific community"

Gian Paolo Andreoletti, MD, Editor-in-Chief  -  paolo.andreoletti@senology.it

 Educational Grants - Sincere appreciation is extended to the following companies for their generous support of this activity:

     

Subscribe     Unsubscribe     Contact     Back Issues     www.senology.org Home Page

Best Study of the Month

Vote for your favourite study

Literature Selection

Comment

  • "Impact of locoregional treatment on the survival of breast cancer patients with synchronous metastases" - Romuald Le Scodan, Department of Radiation Oncology, Centre René Huguenin, Saint Cloud, France
     
    "We retrospectively studied the impact of locoregional treatment (LRT), consisting mainly of locoregional radiotherapy (LRR) directed to the breast and regional lymphatics, on the survival of breast cancer patients with synchronous metastases. Among 581 eligible patients treated in our institution between 1980 and 2004, 320 received LRT (group A) and 261 received no LRT (group B). With a median follow-up of 39 months, the 3-year OS rates were 43.4% and 26.7% in group A and group B (p=0.00002). The association between LRT and improved survival was particularly marked in women with visceral metastases. LRT was an independent prognostic factor in multivariate analysis (....). Our results confirm the survival advantage conferred by surgery or radiation therapy of the primary tumor in breast cancer patients with synchronous metastases. Well-designed prospective studies, including locoregional radiotherapy as the only locoregional treatment, are needed to re-evaluate treatment of the primary breast tumor in patients with metastases at diagnosis, and to identify those patients who are most likely to benefit"
    (Comment on: Le Scodan R et al.: "Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy"; J Clin Oncol. 2009 Feb 9. [Epub ahead of print])

Press Releases

Images

Cystosarcoma phylloides

Stefano Ciatto, - CSPO - Istituto Scientifico Prevenzione Oncologica, Florence, Italy

Submit an image

Calendar of Events

 

Best Study of the Month

Vote for your favourite study

Literature Selection

Comment

Press Releases

Clinical Guidelines

Healthcare Companies News


Literature Selection

If this e-mail has reached you in error, simply click on the following link and unsubscribe yourself Unsubscribe

Contact info - For advertising information please contact: A&B@senology.it . For other enquiries, problems or suggestions please contact: staff@senology.it

© A&B Edizioni Medico-Scientifiche - Milan,  Italy.  Fax: +39.035.7171000

       www.senology.orgorg

www.senology.org